Viewing Study NCT05175950


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-01-22 @ 9:46 AM
Study NCT ID: NCT05175950
Status: UNKNOWN
Last Update Posted: 2023-02-14
First Post: 2022-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)
Sponsor: Korea University Guro Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IIS_2021_001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER_GOV View